1 / 38

Dengue Fever Manual

Dengue Fever Manual. Department of Medicine Lahore General Hospital/PGMI Lahore. Dengue Fever. Dengue virus Most prevalent vector-borne viral illness in the world Main mosquito vector is Aedes Aegypti and Albopictus Year round transmission. Incidence.

aiko-stark
Download Presentation

Dengue Fever Manual

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Dengue FeverManual Department of Medicine Lahore General Hospital/PGMI Lahore

  2. Dengue Fever • Dengue virus • Most prevalent vector-borne viral illness in the world • Main mosquito vector is Aedes Aegypti and Albopictus • Year round transmission

  3. Incidence • 50-100 million dengue fever infections per year globally • 500,000 cases of severe dengue, dengue hemorrhagic fever or dengue shock syndrome • 100-200 cases annually in U.S. • Average case fatality 5%

  4. Distribution • Endemic in more than 100 tropical and subtropical countries • Pandemic began in Southeast Asia after WW II with subsequent global spread • Several epidemics since 1980s • Distribution is comparable to malaria

  5. Virology • Flavivirus family • Small enveloped viruses containing single stranded positive RNA • Four distinct viral serotypes (Den-1, Den-2, Den-3, Den-4)

  6. Pathophysiology • Transmitted by the bite of Aedes mosquito (Aedes aegypti and albopictus) • Incubation 3-14 days • Acute illness and viremia 3-7 days • Recovery or progression to leakage phase

  7. Clinical Presentation • Spectrum of illness • non-specific febrile illness • classic dengue • dengue hemorrhagic fever • dengue shock syndrome • other (CNS dysfunction, liver failure, myocarditis)

  8. The course of dengue illness 3 Phases Febrile Phase Critical Phase Recovery Phase

  9. Differential Diagnosis of Dengue Fever

  10. D/D of Dengue Fever

  11. D/D of Dengue Fever

  12. Approach to a Patient with Dengue Fever

  13. Approach to a patient with Dengue Fever

  14. Treatment Recommendations

  15. Step I—Overall assessment History The history should include: – date of onset of fever/illness; – quantity of oral intake; – assessment for warning signs ; – diarrhea; – change in mental state/seizure/dizziness; – urine output (frequency, volume and time of last voiding); – other important relevant histories, such as family or neighborhood dengue, co-existing conditions (e.g. infancy, pregnancy, obesity, diabetes mellitus, hypertension),

  16. Step I—Overall assessment Physical examination The physical examination should include: • – assessment of mental state; • – assessment of hydration status; • – assessment of hemodynamic status • – checking for tachypnoea/acidotic breathing/pleural effusion; • – checking for abdominal pain, tenderness/hepatomegaly/ascites; • – examination for rash and bleeding manifestations; • – tourniquet test (repeat if previously negative or if there is no bleeding manifestation).

  17. Step I—Overall assessment Investigations: • CBC , PLATELET COUNT, HCT • ELECTROLYTES, CREATININE, BICARBONATE, BSR • LFT’S • URINE C/E • BLOOD GROUP

  18. Step II—Diagnosis, assessment of disease phase and severity • On the basis of evaluations of the history, physical examination and/or full blood count and haematocrit, confirm. • The diagnosis as dengue. • assess the phase (febrile, critical or recovery) • Presence of warning signs • The hydration and hemodynamic status o • Needs for admission and/or referral to emergency department.

  19. Step II—Diagnosis, assessment of disease phase and severity Hospital Admission Criteria • Warning signs Any of the warning signs if present.

  20. Step II—Diagnosis, assessment of disease phase and severity Hospital Admission Criteria

  21. Monitoring of Dengue Fever Patients • Feeling of well being • Fever • Pulse pressure, Blood pressure and Heart rate • Vomiting/loose stool and oral intake • Urine output • Blood counts specially HCT

  22. Management decisions Depending on the clinical manifestations and other circumstances, • Patients may be sent home (Group A) • Referred for in-hospital management or (Group B) • Require emergency treatment and urgent referral (Group C).

  23. Home care for dengue (OPD care - Group A) • Home care card for dengue • Adequate bed rest • Adequate fluid intake (>5 glasses for average-sized adults or accordingly in children) • Milk, fruit juice (caution with diabetes patient) and isotonic electrolyte solution (ORS) and barley/rice water. • - Plain water alone may cause electrolyte imbalance. • Take paracetamol (not more than 8tabs (4 Gm) per day for adults and accordingly in children) • Tepid sponging with water or cold water shower • Look for mosquito breeding places in and around the home and eliminate them

  24. Home care for dengue What should be avoided? • • Do not take acetylsalicylic acid (aspirin), mefenemic acid (ponstan), ibuprofen or other non-steroidal anti-inflammatory agents (NSAIDs), or steroids. • • Antibiotics are not required and they are best avoided.

  25. Home care for dengue Approach the hospital staff early if • Bleeding • Red spots or patches on the skin • Bleeding from nose or gums • Vomiting blood • Black-colored stools • Heavy menstruation/vaginal bleeding • Frequent vomiting • Severe abdominal pain • Drowsiness, mental confusion or seizures • Pale, cold or clammy hands and feet • Difficulty in breathing

  26. In hospital management for dengue (Group B) Compensated shock (systolic pressure) maintained but has signs of reduced perfusion) Fluid resuscitation with isotonic crystalloid 5-10 ml/kg/hr over 1 hour Improvement YES NO Check HCT IV crystalloid 5-7 ml/kg/hr for 1-2 hours, then: HCT or high reduce to 3-5 ml/kg/hr for 2-4 hours; reduce to 2-3 ml/kg/hr for 2-4 hours. HCT If patient continues to improve, fluid can be further reduced. Consider significant occult/overt bleed Administer 2nd bolus of fluid Monitor HCT 6-8 hourly. 10-20 ml/kg/hr for 1 hour Initiate transfusion with fresh whole If the patient is not stable, act according blood to HCT levels: if HCT increases, consider bolus fluid administration or increase fluid administration; if HCT decreases, consider transfusion with Improvement fresh whole transfusion. NO YES Stop at 48 hours. If patient improves, reduce to 7-10 ml/kg/hr for 1-2 hours Then reduce further

  27. In Hospital Management of Dengue Fever (Group C – Emergency care)

  28. Hypotensive shock I/V fluid 20ml / kg isotonic crystalloid or colloid over 15 min Improvement YES NO Review 1st HCT Crystalloid/colloid 10 ml/kg/hr for 1 hour, then continue with: IV crystalloid 5-7 ml/kg/hr for 1- 2 hours; HCT or high reduce to 3-5 ml/kg/hr for 2-4 hours; HCT reduce to 2-3 ml/kg/hr for 2-4 hours. If patient continues to improve, fluid can be Consider significant occult/overt bleed Administer 2nd bolus fluid (colloid) further reduced. 10-20 ml/kg over ½ to 1 hour Initiate transfusion with fresh whole Monitor HCT 6-hourly. If the patient is not stable, act according to HCT levels: blood if HCT increases, consider bolus fluid administration or increase fluid administration; Improvement if HCT decreases, consider transfusion with fresh whole transfusion. Stop at 48 hours. YES NO Repeat 2nd HCT HCT HCT or high Administer 3rd bolus fluid (colloid) 10-20 ml/kg over 1 hour Improvement YES NO Repeat 3rd HCT

  29. Complications of Dengue Fever • Haemorrhagic complications • Fluid overload • Ascites, Pleural effusion, Pulmonary aedema • Metabolic acidosis and electrolyte imbalance • Severe shock • Acute Respiratory Distress Syndrome • Hyperglycaemia and hypoglycaemia • Nosocomial infections • Mycocarditis • Hepatitis

  30. Vaccination • No current dengue vaccine • Estimated availability in 5-10 years • Vaccine development is problematic as the vaccine must provide immunity to all 4 serotypes • Lack of dengue animal model • Live attenuated tetravalent vaccines under phase 2 trials • New approaches include infectious clone DNA and naked DNA vaccines

  31. Hospital Discharge Criteria

  32. Do and don’t of Dengue Fever

  33. Prevention Personal: • clothing to reduce exposed skin • insect repellent especially in early morning, late afternoon. Bed netting is of little utility. Environmental: • reduced vector breeding sites • solid waste management • public education

  34. Prevention Biological: • Target larval stage of Aedes in large water storage containers • Larvivorous fish (Gambusia), endotoxin producing bacteria (Bacillus), copepod crustaceans (mesocyclops) Chemical: • Insecticide treatment of water containers • Space spraying (thermal fogs)

  35. Public Health • Major and escalating global public health problem • Global demographic changes: urbanization and population growth with substandard housing, water, and waster management systems • Deteriorating public health infrastructure with limited resources resulting in “crisis management” not prevention • Increased travel • Lack of effective mosquito control

  36. THANK YOU

More Related